Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences?

Background. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected >160 million people around the world. Hypertension (HT), chronic heart disease (CHD), and diabetes mellitus (DM) increase susceptibility to SARS-CoV-2 infection. Aims. We designed this retrospective study to ass...

Full description

Bibliographic Details
Main Authors: Tiziana Ciarambino, Filippina Ciaburri, Venere Delli Paoli, Giuseppe Caruso, Mauro Giordano, Maria D’Avino
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/16/3740
id doaj-997ebb61159b46d1b376d52ead708e26
record_format Article
spelling doaj-997ebb61159b46d1b376d52ead708e262021-08-26T13:56:08ZengMDPI AGJournal of Clinical Medicine2077-03832021-08-01103740374010.3390/jcm10163740Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences?Tiziana Ciarambino0Filippina Ciaburri1Venere Delli Paoli2Giuseppe Caruso3Mauro Giordano4Maria D’Avino5Internal Medicine Department, Hospital of Marcianise, 81037 Caserta, ItalyHypertension Unit, Cardarelli Hospital, Naples 80110, ItalyInternal Medicine Department, Cardarelli Hospital, 80110 Naples, ItalyHypertension Unit, Cardarelli Hospital, Naples 80110, ItalyInternal Medicine Department, University of Campania, L. Vanvitelli, 80110 Naples, ItalyHypertension Unit, Cardarelli Hospital, Naples 80110, ItalyBackground. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected >160 million people around the world. Hypertension (HT), chronic heart disease (CHD), and diabetes mellitus (DM) increase susceptibility to SARS-CoV-2 infection. Aims. We designed this retrospective study to assess the gender differences in hypertensive diabetic SARS-CoV-2 patients. We reported data, by gender differences, on the inflammatory status, on the hospital stays, intensive care unit (ICU) admission, Rx and CT report, and therapy. Methods. We enrolled 1014 patients with confirmed COVID-19 admitted into different Hospitals of Campania from 26 March to 30 June, 2020. All patients were allocated into two groups: diabetic-hypertensive group (DM-HT group) that includes 556 patients affected by diabetes mellitus and arterial hypertension and the non-diabetic- non-hypertensive group (non-DM, non-HT group) comprising 458 patients. The clinical outcomes (i.e., discharges, mortality, length of stay, therapy, and admission to intensive care) were monitored up to June 30, 2020. Results. We described, in the DM-HT group, higher proportion of cardiopathy ischemic (CHD) (47.5% vs. 14.8%, respectively; <i>p</i> < 0.0001) and lung diseases in females compared to male subjects (34.8% vs. 18.5%, respectively; <i>p</i> < 0.0001). In male subjects, we observed higher proportion of kidney diseases (CKD) (11% vs. 0.01%, respectively; <i>p</i> < 0.0001), a higher hospital stay compared to female subjects (22 days vs. 17 days, respectively, <i>p</i> < 0.0001), a higher admission in ICU (66.9% vs. 12.8%, respectively, <i>p</i> < 0.0001), and higher death rate (17.3% vs. 10.7%, respectively, <i>p</i> < 0.0001). Conclusion. These data confirm that male subjects, compared to female subjects, have a higher hospital stay, a higher admission to ICU, and higher death rate.https://www.mdpi.com/2077-0383/10/16/3740COVID-19 infectiondiabetes mellitusarterial hypertensionSARS-CoV-2outcomecomorbidity
collection DOAJ
language English
format Article
sources DOAJ
author Tiziana Ciarambino
Filippina Ciaburri
Venere Delli Paoli
Giuseppe Caruso
Mauro Giordano
Maria D’Avino
spellingShingle Tiziana Ciarambino
Filippina Ciaburri
Venere Delli Paoli
Giuseppe Caruso
Mauro Giordano
Maria D’Avino
Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences?
Journal of Clinical Medicine
COVID-19 infection
diabetes mellitus
arterial hypertension
SARS-CoV-2
outcome
comorbidity
author_facet Tiziana Ciarambino
Filippina Ciaburri
Venere Delli Paoli
Giuseppe Caruso
Mauro Giordano
Maria D’Avino
author_sort Tiziana Ciarambino
title Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences?
title_short Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences?
title_full Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences?
title_fullStr Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences?
title_full_unstemmed Arterial Hypertension and Diabetes Mellitus in COVID-19 Patients: What Is Known by Gender Differences?
title_sort arterial hypertension and diabetes mellitus in covid-19 patients: what is known by gender differences?
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2021-08-01
description Background. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected >160 million people around the world. Hypertension (HT), chronic heart disease (CHD), and diabetes mellitus (DM) increase susceptibility to SARS-CoV-2 infection. Aims. We designed this retrospective study to assess the gender differences in hypertensive diabetic SARS-CoV-2 patients. We reported data, by gender differences, on the inflammatory status, on the hospital stays, intensive care unit (ICU) admission, Rx and CT report, and therapy. Methods. We enrolled 1014 patients with confirmed COVID-19 admitted into different Hospitals of Campania from 26 March to 30 June, 2020. All patients were allocated into two groups: diabetic-hypertensive group (DM-HT group) that includes 556 patients affected by diabetes mellitus and arterial hypertension and the non-diabetic- non-hypertensive group (non-DM, non-HT group) comprising 458 patients. The clinical outcomes (i.e., discharges, mortality, length of stay, therapy, and admission to intensive care) were monitored up to June 30, 2020. Results. We described, in the DM-HT group, higher proportion of cardiopathy ischemic (CHD) (47.5% vs. 14.8%, respectively; <i>p</i> < 0.0001) and lung diseases in females compared to male subjects (34.8% vs. 18.5%, respectively; <i>p</i> < 0.0001). In male subjects, we observed higher proportion of kidney diseases (CKD) (11% vs. 0.01%, respectively; <i>p</i> < 0.0001), a higher hospital stay compared to female subjects (22 days vs. 17 days, respectively, <i>p</i> < 0.0001), a higher admission in ICU (66.9% vs. 12.8%, respectively, <i>p</i> < 0.0001), and higher death rate (17.3% vs. 10.7%, respectively, <i>p</i> < 0.0001). Conclusion. These data confirm that male subjects, compared to female subjects, have a higher hospital stay, a higher admission to ICU, and higher death rate.
topic COVID-19 infection
diabetes mellitus
arterial hypertension
SARS-CoV-2
outcome
comorbidity
url https://www.mdpi.com/2077-0383/10/16/3740
work_keys_str_mv AT tizianaciarambino arterialhypertensionanddiabetesmellitusincovid19patientswhatisknownbygenderdifferences
AT filippinaciaburri arterialhypertensionanddiabetesmellitusincovid19patientswhatisknownbygenderdifferences
AT veneredellipaoli arterialhypertensionanddiabetesmellitusincovid19patientswhatisknownbygenderdifferences
AT giuseppecaruso arterialhypertensionanddiabetesmellitusincovid19patientswhatisknownbygenderdifferences
AT maurogiordano arterialhypertensionanddiabetesmellitusincovid19patientswhatisknownbygenderdifferences
AT mariadavino arterialhypertensionanddiabetesmellitusincovid19patientswhatisknownbygenderdifferences
_version_ 1721192312013324288